Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:54:59 EDT Mon 11 May 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:MDNA from 2025-05-12 to 2026-05-11 - 31 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2026-04-30 07:30C:MDNAMEDICENNA THERAPEUTICS CORP. J0.60News ReleaseMedicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
2026-04-21 17:43C:MDNAMedicenna Therapeutics Corp0.59News ReleaseMedicenna releases MDNA113 preclinical data
2026-04-14 07:30C:MDNAMEDICENNA THERAPEUTICS CORP. J0.615News ReleaseMedicenna to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
2026-04-09 12:49C:MDNAMedicenna Therapeutics Corp0.65News ReleaseMedicenna appoints Ibrahim as chief medical officer
2026-03-18 07:30C:MDNAMEDICENNA THERAPEUTICS CORP. J0.76News ReleaseMedicenna to Present Preclinical Data from its First-in-Class Tumor Anchored and Conditionally Activated Anti-PD-1-IL-2 Bifunctional Superkine at the AACR Annual Meeting 2026
2026-02-18 07:30C:MDNAMEDICENNA THERAPEUTICS CORP. J0.82News ReleaseMedicenna Therapeutics Announces Participation in Upcoming Conferences
2026-02-13 15:24C:MDNAMedicenna Therapeutics Corp0.83News ReleaseMedicenna's Dec. 31 cash at $10.6-million
2026-02-13 12:25C:MDNAMedicenna Therapeutics Corp0.76News ReleaseMedicenna appoints Sutin, Georgakis as directors
2026-02-12 21:04C:MDNAMedicenna Therapeutics Corp0.76SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-02-12 21:04C:MDNAMedicenna Therapeutics Corp0.76SEDAR Interim MD & ASEDAR Interim MD & A
2026-01-15 17:45C:MDNAMedicenna Therapeutics Corp0.93News ReleaseMedicenna sets out plans, milestones for 2026
2025-12-10 07:30C:MDNAMEDICENNA THERAPEUTICS CORP. J1.61News ReleaseMedicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
2025-12-09 17:04C:MDNAMEDICENNA THERAPEUTICS CORP. J1.61News ReleaseMedicenna Therapeutics to Host a Live Webinar with Q&A to Discuss Updated MDNA11 Clinical Data
2025-11-13 17:43C:MDNAMedicenna Therapeutics Corp1.37News ReleaseMedicenna's fiscal Q2 2026 R&D expenses at $4.1M
2025-11-12 19:36C:MDNAMedicenna Therapeutics Corp1.38SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 19:36C:MDNAMedicenna Therapeutics Corp1.38SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-06 12:56C:MDNAMedicenna Therapeutics Corp1.53News ReleaseMedicenna joins Fondazione Melanoma for MDNA11 trial
2025-10-23 17:12C:MDNAMEDICENNA THERAPEUTICS CORP. J1.06News ReleaseUpdated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
2025-10-20 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J0.90News ReleaseMedicenna Therapeutics Announces Participation in Upcoming Conferences
2025-10-01 09:35C:MDNAMEDICENNA THERAPEUTICS CORP. J0.98News ReleaseROTH to Host 4th Annual Healthcare Opportunities Conference on October 9 in New York City
2025-10-01 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J0.98News ReleaseMedicenna Therapeutics to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
2025-09-25 21:19C:MDNAMedicenna Therapeutics Corp0.94News ReleaseMedicenna shareholders approve AGM resolutions
2025-09-05 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J1.06News ReleaseMedicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-01 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J0.84News ReleaseMedicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
2025-07-31 19:10C:MDNAMedicenna Therapeutics Corp0.84SEDAR Interim MD & ASEDAR Interim MD & A
2025-07-31 19:05C:MDNAMedicenna Therapeutics Corp0.84SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-07-31 16:56C:MDNAMedicenna Therapeutics Corp0.84News ReleaseMedicenna receives five IL-2 and IL-4 superkine patents
2025-06-26 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J0.91News ReleaseMedicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
2025-06-25 21:11C:MDNAMedicenna Therapeutics Corp0.91SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 21:05C:MDNAMedicenna Therapeutics Corp0.91SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 21:05C:MDNAMedicenna Therapeutics Corp0.91SEDAR MD & ASEDAR MD & A